IDEXX LABORATORIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 509.8 USD | +1.80% |
|
+6.08% | -8.15% |
| May. 02 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
| May. 02 | Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675 | MT |
Presenter SpeechJay Mazelsky (Executives)Good morning, and welcome to IDEXX' 2022 Investor Day...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows:
- veterinary diagnoses for pets (91.6%);
- water quality analysis (4.6%);
- veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products;
- other (0.5%).
Net sales by source of income break down between product sales (57.1%) and services (42.9%).
Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
509.8
USD
Average target price
565.8
USD
Spread / Average Target
+10.98%
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- Transcript : IDEXX Laboratories, Inc. - Analyst/Investor Day
